Sine Hadrup

Company: pokeAcell

Job title: Chief Scientific Officer

Seminars:

Developing Multi-Specific Autologous T Cell Therapy Targeting Tumour Neoantigens 9:30 am

Understanding pokeAcell’s ImmPACT technology – Simple expansion of neoantigen-specific T cells directly from blood Exploring how AI-predicted neoantigens are utilised to generate a multi-specific polyclonal functional T cell productRead more

day: Day Two